Telemetry Investments’s Vaccinex, Inc. Common Stock VCNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$268K Sell
1,981
-352
-15% -$43.6K 0.42% 60
2022
Q3
$243K Buy
2,333
+4
+0.2% +$785 0.31% 77
2022
Q2
$528K Sell
2,329
-242
-9% -$61.8K 0.63% 46
2022
Q1
$713K Buy
2,571
+1,938
+306% +$536K 1.13% 30
2021
Q4
$138K Buy
633
+2
+0.3% +$721 0.18% 121
2021
Q3
$286K Buy
631
+60
+11% +$29.9K 0.39% 88
2021
Q2
$336K Buy
571
+71
+14% +$37.5K 0.46% 71
2021
Q1
$313K Buy
500
+138
+38% +$88.7K 0.35% 91
2020
Q4
$157K Buy
362
+84
+30% +$35.1K 0.27% 85
2020
Q3
$104K Buy
+278
New +$303K 0.23% 65
2019
Q3
Sell
-58
Closed -$67K 70
2019
Q2
$67K Sell
58
-48
-45% -$64K 0.05% 78
2019
Q1
$118K Buy
106
+36
+51% +$34.6K 0.06% 90
2018
Q4
$54K Buy
70
+15
+27% +$18.3K 0.03% 130
2018
Q3
$85K Buy
+55
New +$114K 0.04% 112

Other funds holding VCNX

Telemetry Investments's VCNX Position: Q4 2022 in Review

Telemetry Investments reduced its Vaccinex, Inc. Common Stock (VCNX) stake by 15% in Q4 2022, selling an estimated $43.6K and leaving 1,981 shares worth $268K. The position accounts for 0.42% of the portfolio, ranked #60.

Telemetry Investments first reported a position in VCNX in Q3 2018 and has held it in 14 quarters since. The position peaked at $713K in Q1 2022. 24 funds tracked by Wall St. Rank hold VCNX as of Q4 2022.

  • Telemetry Investments held 1,981 shares of Vaccinex, Inc. Common Stock worth $268K as of Q4 2022.
  • Telemetry Investments sold 352 Vaccinex, Inc. Common Stock shares in Q4 2022, an estimated $43.6K.
  • Vaccinex, Inc. Common Stock made up 0.42% of Telemetry Investments's portfolio in Q4 2022, its #60 holding.
  • Telemetry Investments first reported a position in Vaccinex, Inc. Common Stock in Q3 2018 and has held it in 14 quarters since.
  • Telemetry Investments's Vaccinex, Inc. Common Stock position peaked at $713K in Q1 2022.
  • 24 funds tracked by Wall St. Rank held Vaccinex, Inc. Common Stock as of Q4 2022.

Based on Telemetry Investments's 13F filing for Q4 2022, filed 14 Feb 2023.